Cargando…
A dual immune signature of CD8+ T cells and MMP9 improves the survival of patients with hepatocellular carcinoma
The 5-year survival of hepatocellular carcinoma (HCC) is difficult due to the high recurrence rate and metastasis. Tumor infiltrating immune cells (TICs) and immune-related genes (IRGs) bring hope to improve survival and treatment of HCC patients. However, there are problems in predicting immune sig...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Portland Press Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969702/ https://www.ncbi.nlm.nih.gov/pubmed/33656546 http://dx.doi.org/10.1042/BSR20204219 |